Viewing Study NCT07128550

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2026-03-17 @ 12:59 PM
Study NCT ID: NCT07128550
Status: RECRUITING
Last Update Posted: 2025-11-12
First Post: 2025-08-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide
Sponsor: Vir Biotechnology, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Viral Hepatitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HDV View
None Hepatitis D Virus View
None Hepatitis View
None Chronic Hepatitis D Virus View
None Hepatitis D View
None Hepatitis D, Chronic View
None Hepatitis Delta Virus View
None Digestive System Diseases View
None Liver Diseases View